The Oncology Institute, Inc. (TOI)
USD 0.19
(-2.0%)
USD 0.19
(-2.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 219.41 Million USD | -16.81% |
| 2022 | 263.74 Million USD | 29.65% |
| 2021 | 203.43 Million USD | 209.7% |
| 2020 | 65.68 Million USD | 10.36% |
| 2019 | 59.52 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 179.6 Million USD | -12.19% |
| 2024 Q1 | 204.53 Million USD | -6.78% |
| 2023 Q1 | 234.63 Million USD | -11.04% |
| 2023 Q3 | 218.35 Million USD | -5.05% |
| 2023 FY | 219.41 Million USD | -16.81% |
| 2023 Q2 | 229.95 Million USD | -1.99% |
| 2023 Q4 | 219.41 Million USD | 0.49% |
| 2022 Q4 | 263.74 Million USD | -7.07% |
| 2022 FY | 263.74 Million USD | 29.65% |
| 2022 Q3 | 283.8 Million USD | 49.57% |
| 2022 Q2 | 189.74 Million USD | -8.12% |
| 2022 Q1 | 206.51 Million USD | 1.51% |
| 2021 FY | 203.43 Million USD | 209.7% |
| 2021 Q1 | 231.03 Million USD | 251.71% |
| 2021 Q3 | 230.29 Million USD | 168.4% |
| 2021 Q2 | 85.8 Million USD | -62.86% |
| 2021 Q4 | 203.43 Million USD | -11.66% |
| 2020 FY | 65.68 Million USD | 10.36% |
| 2020 Q4 | 65.68 Million USD | -71.61% |
| 2020 Q3 | 231.39 Million USD | -0.03% |
| 2020 Q2 | 231.46 Million USD | -0.16% |
| 2020 Q1 | 231.84 Million USD | 0.0% |
| 2019 FY | 59.52 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 95.905% |
| Addus HomeCare Corporation | 1.02 Billion USD | 78.581% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | -2.747% |
| Amedisys, Inc. | 2.06 Billion USD | 89.35% |
| American Oncology Network, Inc. | 374.45 Million USD | 41.403% |
| Astrana Health, Inc. | 933.36 Million USD | 76.492% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 86.598% |
| IMAC Holdings, Inc. | 1.14 Million USD | -19077.9% |
| biote Corp. | 155.29 Million USD | -41.291% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -258.405% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | 67.7% |
| COMPASS Pathways plc | 275.98 Million USD | 20.497% |
| DocGo Inc. | 490.45 Million USD | 55.262% |
| The Ensign Group, Inc. | 4.17 Billion USD | 94.748% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 72.681% |
| InnovAge Holding Corp. | 547.66 Million USD | 59.935% |
| Assure Holdings Corp. | 7.51 Million USD | -2820.122% |
| The Joint Corp. | 87.15 Million USD | -151.768% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 90.175% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -2659.761% |
| ModivCare Inc. | 1.76 Billion USD | 87.584% |
| NewGenIvf Group Limited | 1.64 Million USD | -13218.563% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -516.983% |
| Option Care Health, Inc. | 3.32 Billion USD | 93.408% |
| P3 Health Partners Inc. | 860.96 Million USD | 74.515% |
| P3 Health Partners Inc. | 860.96 Million USD | 74.515% |
| The Pennant Group, Inc. | 539.69 Million USD | 59.344% |
| Surgery Partners, Inc. | 7.01 Billion USD | 96.874% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -4356.742% |
| Talkspace, Inc. | 142.22 Million USD | -54.28% |
| Talkspace, Inc. | 142.22 Million USD | -54.28% |
| The Oncology Institute, Inc. | 219.41 Million USD | 0.0% |